Angela LaRosa

Concepts (112)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Down Syndrome
8
2020
119
1.970
Why?
Central Nervous System Stimulants
5
2022
221
1.220
Why?
Attention Deficit Disorder with Hyperactivity
4
2022
189
1.120
Why?
Autism Spectrum Disorder
3
2022
111
0.940
Why?
Attention Deficit and Disruptive Behavior Disorders
1
2019
29
0.710
Why?
Adrenergic alpha-Agonists
1
2019
57
0.710
Why?
Anemia, Iron-Deficiency
1
2020
34
0.700
Why?
Treatment Refusal
1
2019
40
0.690
Why?
Child, Preschool
13
2022
3185
0.640
Why?
Intellectual Disability
1
2019
114
0.640
Why?
Practice Guidelines as Topic
1
2020
772
0.510
Why?
Sleep Apnea Syndromes
1
2015
40
0.500
Why?
Sleep Apnea, Obstructive
4
2017
142
0.500
Why?
Developmental Disabilities
2
2012
119
0.500
Why?
Tonsillectomy
4
2017
69
0.460
Why?
Methylphenidate
3
2021
97
0.450
Why?
Child Behavior Disorders
1
2012
69
0.420
Why?
Parents
2
2019
309
0.420
Why?
Mass Screening
3
2012
837
0.400
Why?
Child
12
2022
6400
0.360
Why?
Adenoidectomy
3
2017
51
0.330
Why?
Child Development
1
2009
102
0.330
Why?
Parenting
1
2009
91
0.330
Why?
Exosomes
2
2019
44
0.310
Why?
Health Status
1
2009
429
0.280
Why?
Adolescent
10
2020
8903
0.280
Why?
Infant
6
2020
2891
0.250
Why?
Cross-Sectional Studies
3
2019
2264
0.250
Why?
Comorbidity
2
2020
1425
0.230
Why?
Retrospective Studies
5
2022
7264
0.210
Why?
Depression
1
2009
942
0.210
Why?
Guanfacine
1
2021
6
0.200
Why?
Adrenergic alpha-2 Receptor Agonists
1
2021
11
0.200
Why?
Humans
18
2022
68525
0.200
Why?
Sleep Wake Disorders
1
2022
94
0.200
Why?
Male
12
2021
37281
0.190
Why?
Female
12
2021
38015
0.190
Why?
Electronic Health Records
2
2021
374
0.180
Why?
Protective Devices
1
2019
13
0.180
Why?
Extracellular Vesicles
1
2019
21
0.180
Why?
Communication Disorders
1
2019
12
0.170
Why?
Amphetamine
1
2019
77
0.170
Why?
Endocytosis
1
2019
113
0.170
Why?
Insurance, Health
1
2019
200
0.160
Why?
Societies, Medical
1
2020
403
0.150
Why?
Medicaid
1
2019
301
0.150
Why?
Weight Gain
1
2017
135
0.140
Why?
Pediatrics
1
2020
341
0.140
Why?
Schools
2
2021
156
0.130
Why?
Sleep Apnea, Central
1
2015
6
0.130
Why?
Hypoventilation
1
2015
8
0.130
Why?
Facial Bones
1
2015
10
0.130
Why?
Practice Patterns, Physicians'
1
2019
503
0.130
Why?
Age Factors
1
2019
1860
0.130
Why?
Pharynx
1
2015
89
0.120
Why?
South Carolina
1
2020
2750
0.110
Why?
Risk Assessment
1
2019
2004
0.110
Why?
Early Diagnosis
1
2012
122
0.110
Why?
Physicians, Primary Care
1
2012
46
0.110
Why?
Cognition Disorders
1
2015
342
0.100
Why?
Alzheimer Disease
1
2016
563
0.100
Why?
United States
3
2019
7335
0.100
Why?
Attention
1
2012
225
0.090
Why?
Psychometrics
1
2012
514
0.090
Why?
Evidence-Based Practice
1
2011
146
0.090
Why?
Residence Characteristics
1
2011
252
0.080
Why?
Parent-Child Relations
1
2009
98
0.080
Why?
Infant, Newborn
2
2017
2453
0.080
Why?
Anemia, Sickle Cell
1
2012
364
0.080
Why?
Obesity
1
2015
1074
0.080
Why?
Health Promotion
1
2011
407
0.070
Why?
Psychiatric Status Rating Scales
1
2009
782
0.070
Why?
Postoperative Period
2
2017
238
0.070
Why?
Young Adult
4
2017
5708
0.070
Why?
Logistic Models
1
2009
1419
0.070
Why?
Irritable Mood
1
2021
15
0.050
Why?
Medication Therapy Management
1
2021
32
0.050
Why?
Disorders of Excessive Somnolence
1
2021
28
0.050
Why?
Telephone
1
2021
160
0.050
Why?
Educational Status
1
2021
273
0.050
Why?
Adult
2
2017
21375
0.050
Why?
Feeding and Eating Disorders
1
2021
106
0.040
Why?
Cell Communication
1
2019
116
0.040
Why?
Palate
1
2017
14
0.040
Why?
Tongue
1
2017
20
0.040
Why?
Tracheostomy
1
2017
31
0.040
Why?
Postoperative Hemorrhage
1
2017
69
0.040
Why?
Polysomnography
1
2017
92
0.040
Why?
tau Proteins
1
2016
61
0.040
Why?
Amyloid beta-Peptides
1
2016
190
0.030
Why?
Combined Modality Therapy
1
2017
951
0.030
Why?
Peptide Fragments
1
2016
483
0.030
Why?
Body Mass Index
1
2017
866
0.030
Why?
Treatment Outcome
2
2017
7028
0.030
Why?
Reaction Time
1
2012
170
0.030
Why?
Hospitalization
1
2017
977
0.030
Why?
Healthy People Programs
1
2011
13
0.020
Why?
Cohort Studies
1
2017
2356
0.020
Why?
Biomarkers
1
2016
1593
0.020
Why?
Fragile X Syndrome
1
2010
17
0.020
Why?
Smoking Prevention
1
2011
259
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2010
320
0.020
Why?
Middle Aged
2
2017
21119
0.020
Why?
Cognition
1
2012
512
0.020
Why?
Double-Blind Method
1
2012
1737
0.020
Why?
Pilot Projects
1
2012
1341
0.020
Why?
Wounds and Injuries
1
2011
334
0.020
Why?
Diet
1
2011
513
0.020
Why?
Exercise
1
2011
657
0.020
Why?
Animals
1
2019
20877
0.010
Why?
Substance-Related Disorders
1
2011
1241
0.010
Why?
Magnetic Resonance Imaging
1
2010
2222
0.010
Why?
LaRosa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (112)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_